ONCS.D Insider Trading Activity and SEC Form 4 Filings
ONCS.D insider trading summary
No open-market insider purchases or sales of ONCOSEC MEDICAL Inc (ONCS.D) have been reported on SEC Form 4 in the past 12 months.
Latest ONCS.D insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 1, 2011 | Avtar S Dhillon | Director | Buy | $3K (9,910,480 @ $0.00) |
| Mar 1, 2011 | Punit Dhillon | President and CEO | Buy | $1K (3,642,000 @ $0.00) |
| Mar 1, 2011 | Punit Dhillon | President and CEO | Buy | $7 (25,000 @ $0.00) |
| Mar 1, 2011 | Veronica Vallejo | Principal Financial Officer | Buy | $60 (200,000 @ $0.00) |
| Mar 1, 2011 | Punit Dhillon | President and CEO | Buy | $36 (120,000 @ $0.00) |
| Mar 1, 2011 | Punit Dhillon | President and CEO | Buy | $182 (607,000 @ $0.00) |
| Mar 1, 2011 | James M Demesa | Director | Buy | $75 (250,000 @ $0.00) |
| Mar 1, 2011 | Michael Cross | Chief Operating Officer | Buy | $364 (1,214,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.